Yarrow Bioscience, Inc. (YARW) stock
YARWNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/30102% above fair value
$14.35+0.14 (+0.99%)
Close on Nov 18, 2026Market cap $38.31MP/E –Yield –
Yarrow Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Yarrow Bioscience's market cap was $12.06M on Nov 11, 2026, against $7.62M a year earlier. Over the last 5 years it ranged from $5.65M to $54.58M, with a median of $20.01M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $12.06M | +5.2% |
| 2025 | Dec 31, 2025 | $11.47M | -76.8% |
| 2024 | Dec 31, 2024 | $49.42M | +541.8% |
| 2023 | Dec 29, 2023 | $7.70M | -11.5% |
| 2022 | Dec 30, 2022 | $8.70M | -84.1% |
| 2021 | Dec 31, 2021 | $54.58M | -79.4% |
| 2020 | Dec 31, 2020 | $265.20M | +138.3% |
| 2019 | Dec 31, 2019 | $111.27M | +16.3% |
| 2018 | Dec 31, 2018 | $95.70M | – |
See a number that looks wrong?